Wortmannin

N/A

Report date: 2022/09/28 20:01:03

Base Information

Drug NameWortmannin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitors
TargetsPI3-kinase class I
Therapy Area/IndicationsGraft vs Host DiseaseNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company +[2] 
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A